ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Multi-Center Validation of TruGraf V2 – A Peripheral Blood Diagnostic for Subclincal Kidney Rejection

C. Marsh1, S. Kurian1, C. Schieve2, R. Heilman3, M. Stegall4, S. Rose2, J. Case1, J. Friedewald5, M. Abecassis5, R. First2

1Scripps Health, La Jolla, CA, 2Transplant Genomics Inc., Mansfield, MA, 3Mayo Clinic, Scottsdale, AZ, 4Mayo Clinic, Rochester, MN, 5Northwestern University, Chicago, IL

Meeting: 2019 American Transplant Congress

Abstract number: B83

Keywords: Genomic markers, Kidney transplantation, Rejection

Session Information

Date: Sunday, June 2, 2019

Session Name: Poster Session B: Biomarkers, Immune Monitoring and Outcomes

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

Related Abstracts
  • Validation of a Peripheral Blood Gene Expression Profile for SubClinical Acute Rejection in Kidney Transplant Recipients – Findings from the CTOT 08 Study
  • Bioinformatics Approach to the Development of a Novel Molecular Biomarker for Sub-Clinical Acute Rejection (subAR) in the Peripheral Blood Following Kidney Transplant (KT)

*Purpose: Unsuspected subclinical acute rejection (subAR) is currently only detectable in 15-25% of invasive surveillance biopsies (SB) and can lead to chronic rejection and poor graft function. TruGraf v1, a CLIA-approved microarray-based blood gene expression minimally-invasive laboratory developed test provides accurate information on potential association with a normal surveillance biopsy (TX) reflecting immune quiescence and adequacy of (IS) in kidney transplant recipients (KTR). A negative test connotes a high probability of a ‘TX’ phenotype, whereas a positive test (non-TX) suggests a possibility of immune activation associated with rejection on a SB. We have recently discovered and validated a new gene expression classifier test (TruGraf v2) that correlates with subAR vs no subAR (TX) in KTR with stable renal function (sKTR). Here, we compare the performance of TruGraf v1 and v2 classifiers vs histology in SB in sKTR at 9 clinical sites.

*Methods: 166 blood samples paired with SB (TX=37; non-TX/subAR=129) were collected in PAXgene tubes and run on Affymetrix HG‐U133+PM Array plates. Gene expression data were analyzed using locked thresholds for each classifier.

*Results: Overall accuracy: 68%, 74%; sensitivity: 57%, 32%; specificity: 71%, 86%; PPV 39%, 43%; NPV 84%, 74% for TruGraf v1 vs v2. Both classifiers called 82 results correctly and 18 results incorrectly. Importantly, TruGraf v2 called 41 phenotypes correctly that were miscalled by TruGraf v1, whereas TruGraf v1 called only 25 phenotypes correctly that were miscalled by TruGraf v2. A McNemar’s test for two outcome variables from a single population had a p-value 0.06, showing the difference in proportions of correct/incorrect calls by the two test versions, with v2 being more accurate.

*Conclusions: A multi-center validation of TruGraf v2 from 9 clinical sites shows similar performance compared with our initial validation cohort. In addition, when compared to an earlier classifier (v1), TruGraf v2 demonstrates better specificity and accuracy compared to v1. This could be attributed to a rigorous discovery and validation based on a cohort consisting exclusively of patients with biopsy-confirmed subAR. TruGraf v2, optimized for ruling out subAR is an improved version of the original v1, providing the ability to use a minimally-invasive blood test as an alternative approach to routinely scheduled SB in sKTR.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Marsh C, Kurian S, Schieve C, Heilman R, Stegall M, Rose S, Case J, Friedewald J, Abecassis M, First R. Multi-Center Validation of TruGraf V2 – A Peripheral Blood Diagnostic for Subclincal Kidney Rejection [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/multi-center-validation-of-trugraf-v2-a-peripheral-blood-diagnostic-for-subclincal-kidney-rejection/. Accessed January 26, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.